Geode Capital Management’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,397
|
|
||||
|
2023
Q4 | $29K | Hold |
4,397
|
|
||||
|
2023
Q3 | $40.9K | Buy |
4,397
+1,199
|
|
||||
|
2023
Q2 | $41.4K | Hold |
3,198
|
|
||||
|
2023
Q1 | $53K | Hold |
3,198
|
|
||||
|
2022
Q4 | $50K | Sell |
3,198
-7
|
|
||||
|
2022
Q3 | $69K | Buy |
3,205
+87
|
|
||||
|
2022
Q2 | $34K | Buy |
3,118
+465
|
|
||||
|
2022
Q1 | $50K | Hold |
2,653
|
|
||||
|
2021
Q4 | $54K | Sell |
2,653
-2
|
|
||||
|
2021
Q3 | $99K | Hold |
2,655
|
|
||||
|
2021
Q2 | $138K | Buy |
2,655
+879
|
|
||||
|
2021
Q1 | $105K | Hold |
1,776
|
|
||||
|
2020
Q4 | $116K | Buy |
1,776
+916
|
|
||||
|
2020
Q3 | $85K | Hold |
860
|
|
||||
|
2020
Q2 | $158K | Buy |
860
+121
|
|
||||
|
2020
Q1 | $103K | Buy |
739
+601
|
|
||||
|
2019
Q4 | $16K | Hold |
138
|
|
||||
|
2019
Q3 | $22K | Hold |
138
|
|
||||
|
2019
Q2 | $105K | Buy |
138
+43
|
|
||||
|
2019
Q1 | $101K | Hold |
95
|
|
||||
|
2018
Q4 | $76K | Buy |
95
+68
|
|
||||
|
2018
Q3 | $19K | Hold |
27
|
|
||||
|
2018
Q2 | $104K | Buy |
27
+3
|
|
||||
|
2018
Q1 | $91K | Hold |
24
|
|
||||
|
2017
Q4 | $115K | Hold |
24
|
|
||||
|
2017
Q3 | $152K | Hold |
24
|
|
||||
|
2017
Q2 | $165K | Sell |
24
-10
|
|
||||
|
2017
Q1 | $402K | Hold |
34
|
|
||||
|
2016
Q4 | $487K | Buy |
34
+3
|
|
||||
|
2016
Q3 | $666K | Buy |
31
+1
|
|
||||
|
2016
Q2 | $595K | Buy |
30
+9
|
|
||||
|
2016
Q1 | $364 | Hold |
21
|
|
||||
|
2015
Q4 | $337K | Buy |
+21
|
|